176 related articles for article (PubMed ID: 35801419)
1. Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy.
Guo Z; Wang Z; Liang R; Tian H; Chen X; Chen M
Bosn J Basic Med Sci; 2022 Oct; 22(6):934-948. PubMed ID: 35801419
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.
Wang Y; Zhang T; Hou C; Zu M; Lu Y; Ma X; Jia D; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2019 Aug; 11(32):29330-29340. PubMed ID: 31329411
[TBL] [Abstract][Full Text] [Related]
3. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J
Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474
[TBL] [Abstract][Full Text] [Related]
4. Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy.
Yuan G; Zhang Y; Shao S; Zhou Z; Tang J; Xiang J; Shen Y
J Control Release; 2023 Sep; 361():792-802. PubMed ID: 37595665
[TBL] [Abstract][Full Text] [Related]
5. A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer.
Liu L; Liu F; Liu D; Yuan W; Zhang M; Wei P; Yi T
Angew Chem Int Ed Engl; 2022 Mar; 61(12):e202116807. PubMed ID: 35068033
[TBL] [Abstract][Full Text] [Related]
6. Helix Self-Assembly Behavior of Amino Acid-Modified Camptothecin Prodrugs and Its Antitumor Effect.
Guo Z; Lin L; Hao K; Wang D; Liu F; Sun P; Yu H; Tang Z; Chen M; Tian H; Chen X
ACS Appl Mater Interfaces; 2020 Feb; 12(6):7466-7476. PubMed ID: 31958004
[TBL] [Abstract][Full Text] [Related]
7. A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling.
Chou HL; Fong Y; Wei CK; Tsai EM; Chen JY; Chang WT; Wu CY; Huang HW; Chiu CC
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):241-252. PubMed ID: 27677293
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species-activatable camptothecin polyprodrug based dextran enhances chemotherapy efficacy by damaging mitochondria.
Zhang T; Ma X; Bai S; Wang Y; Zhang X; Lu Y; Wen F; Xue P; Kang Y; Xu Z
J Mater Chem B; 2020 Feb; 8(6):1245-1255. PubMed ID: 31957760
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.
Zhang W; Hu X; Shen Q; Xing D
Nat Commun; 2019 Apr; 10(1):1704. PubMed ID: 30979885
[TBL] [Abstract][Full Text] [Related]
12. A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts.
Endo M; Miwa M; Ura M; Tanimura H; Taniguchi K; Miyazaki Y; Ohwada J; Tsukazaki M; Niizuma S; Murata T; Ozawa S; Suda H; Ogawa K; Nanba E; Nagao S; Shimma N; Yamada-Okabe H
Cancer Chemother Pharmacol; 2010 Jan; 65(2):363-71. PubMed ID: 19495753
[TBL] [Abstract][Full Text] [Related]
13. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin.
Gong X; Wang Z; Zhang L; Dong W; Wang R; Liu Y; Song S; Hu Q; Du F; Shuang S; Dong C
Colloids Surf B Biointerfaces; 2022 Oct; 218():112712. PubMed ID: 35921692
[TBL] [Abstract][Full Text] [Related]
14. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
16. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
[TBL] [Abstract][Full Text] [Related]
17. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
[No Abstract] [Full Text] [Related]
18. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
[TBL] [Abstract][Full Text] [Related]
19. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy.
Dong H; Huang X; Wu X
Biomater Sci; 2023 Sep; 11(18):6160-6166. PubMed ID: 37548235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
